Home Blog Page 2786

Scientists discover lizards reinvented their armour multiple times | – The Times of India

0
Scientists discover lizards reinvented their armour multiple times | - The Times of India

Scientists discover lizards reinvented their armour multiple times (AI -gemerated)

Biologists have long treated the bony plates found in some lizards as an ancient inheritance, passed down and occasionally lost. New research now suggests a different pattern. A study led by the Museums Victoria Research Institute argues that most of these plates, known as osteoderms, appeared much later and did so repeatedly. The work draws on fossils, modern scans and genetic relationships across hundreds of species. Rather than a single origin, armour seems to have been rebuilt again and again, sometimes long after earlier forms vanished. The findings change how scientists read the lizard record and how they think about adaptation. They also place Australia’s monitor lizards at the centre of a broader story about loss, return and evolutionary flexibility over deep time periods.

Armour in lizards seems to have evolved, disappeared, and then evolved again independently

For decades, textbooks implied that early lizards carried bony skin plates and that later groups either kept or discarded them. The new study, named “Lizards in chain mail: reconstructing the enigmatic past of dermal armour in squamate reptiles” challenges this view. By reconstructing evolutionary histories across squamate reptiles, which include lizards and snakes, researchers found that the earliest lizards almost certainly lacked osteoderms.The trait remained absent for tens of millions of years after lizards first appeared. Armour did not fade from a common starting point. Instead, it arrived late and unevenly.

Multiple origins reshaped the lizard family tree

The research team examined 643 living and extinct species across roughly 320 million years. Using CT scan data, fossil evidence and molecular relationships, they tracked where osteoderms were present or missing.Their results suggest that bony plates evolved at least thirteen times in modern lizard groups. Many of these gains occurred during a narrow window around the Late Jurassic and Early Cretaceous, about 140 million years ago, as major lineages began to diversify. This pattern points to repeated innovation rather than inheritance.

Monitor lizards show loss and return

Monitor lizards stand out within the findings. Evidence suggests that their ancestors lost osteoderms around 72 million years ago. This likely coincided with a shift toward a more active hunting style that favoured speed and flexibility. Early monitors, including the ancestors of Australian goannas, appear to have traded protection for movement. Heavy armour would have slowed pursuit hunting.Much later, during the Miocene, osteoderms returned in several Australian and Papuan monitor lineages. These later forms were lighter and looser, offering some protection without limiting motion.

Environment may have shaped the armour’s comeback

The study suggests that changing environments played a role in the return of armour. As monitor lizards spread into drier regions of Australia, osteoderms may have offered new advantages.Beyond defence, these bony plates can help reduce water loss, store calcium, and support the body during climbing. In this sense, armour may have been reselected for different functions than before. This makes monitor lizards one of the clearest examples of evolutionary re-innovation seen in modern reptiles.

Bony plates serve many quiet functions

Osteoderms are not part of the skeleton. They form within the skin and vary widely in shape and placement. In crocodiles, they help regulate blood chemistry during long periods underwater by releasing calcium.In lizards, their roles are less well understood but appear equally varied. They can act as thermal regulators, water retention structures or simple protection against attack. Despite their importance, their developmental origins remain unclear. This study provides a framework for exploring how such structures form again and again.

Similar looks can hide different histories

The findings help explain why unrelated lizards can look alike. The Gila monster of North America and Australia’s shingleback lizard both appear heavily armoured, yet their similarities arose through different evolutionary paths. This mirrors other repeated innovations in nature, such as flight, which evolved separately in insects, birds and bats.By mapping when and where osteoderms appeared, researchers have added depth to the story of lizard evolution. The picture is uneven and complex. Armour comes and goes. Sometimes it returns. And sometimes, it arrives quietly, shaped by pressures that only become clear much later.

Study reveals how rapidly weight comes back after quitting obesity medications

0
Study reveals how rapidly weight comes back after quitting obesity medications

NEWYou can now listen to Fox News articles!

Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.

The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.

University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.

OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS

On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)

The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

“The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control,” the researchers commented in a press release.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

Woman weighing herself

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)

In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings “cast doubt” on the idea that GLP-1s are a “perfect cure for obesity.”

CLICK HERE FOR MORE HEALTH STORIES

“People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications,” he said. “Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts.”

“Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care.”

“Such practices not only help prevent excess weight gain, but can also lead to numerous health benefits that go beyond weight control.”

Why patients quit

Recent reports have disclosed that more older Americans are deciding to quit their GLP-1s for a variety of reasons.

Additionally, a 2025 study published in JAMA — which included more than 125,000 overweight or obese people — found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them.

person stands on scale holding GLP1 injection

Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, bloating, headaches, fatigue and hair thinning, according to experts. (iStock)

Users and experts have claimed that cost, muscle loss, dehydration and side effects are the most common reasons weight-loss drugs are discontinued.

Side effects often include nausea, vomiting, diarrhea, constipation, bloating, headaches, fatigue and hair thinning, according to experts.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

In a previous interview with Fox News Digital, Dr. Sue Decotiis, a medical weight-loss doctor in New York City, noted that older patients are especially more sensitive to gastrointestinal side effects.

“Careful monitoring by a physician who is knowledgeable in the area of medical weight loss is imperative,” she said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“Often, using a customized dosing plan helps the patient avoid undue side effects and helps them burn more fat, which is the mechanism by which GLP drugs work long-term and systemically,” she went on. “For certain patients, a high-quality compounded GLP-1 can achieve tailored dosing.”

“Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care.”

WATCH: Babar Azam falls for duck in BBL 15 qualifier

0
WATCH: Babar Azam falls for duck in BBL 15 qualifier

Pakistan’s star batter Babar Azam heads to pavilion after losing wicket on the second delivery of his innings during BBL season 15 on January 20, 2026, at Optus Stadium, Australia. — X/@BBL

Pakistan’s batter Babar Azam faced another disappointment during his debut Big Bash League 15 (BBL) season after getting out for a second-ball duck in the Sydney Sixers’ qualifier match against Perth Scorchers at Optus Stadium on Tuesday.

Chasing 148, the Sixers lost Babar early in the innings when he was stumped by Josh Inglis off Cooper Connolly’s bowling in the second delivery of the first over.

Babar has so far featured in 11 BBL matches this season, scoring 202 runs at an average of 22.44 with a strike rate of 103.06, including two fifties.

Earlier, Perth Scorchers posted 147-9 in their 20 overs, struggling to build momentum after early setbacks. Mitchell Marsh was dismissed for just five runs in the opening over, with Josh Starc claiming the key wicket.

Finn Allen and Aaron Hardie steadied the innings, adding crucial runs and helping the team cross the 50-run mark.

However, the partnership ended when Starc struck again, dismissing Allen for 49 off 30 balls, featuring two fours and four sixes.

Wicketkeeper-batter Josh Inglis and Cooper Connolly fell cheaply for two and eight, dismissed by Joel Davies and Ben Manenti, respectively.

Skipper Ashton Turner contributed 29 off 21 balls, including three fours and two sixes, but could not accelerate the innings.

Lower down, Jhye Richardson scored 20 off 18 balls, featuring one boundary and a six, while the rest of the lineup failed to make a notable impact.

For the Sydney Sixers, Josh Starc, Jack Edwards, and Ben Dwarshuis took two wickets each, while Joel Davies and Ben Manenti picked up one wicket apiece.

‘Cusp of historic trade agreement’: EU chief says they are close to signing FTA with India; visit scheduled next week – The Times of India

0
‘Cusp of historic trade agreement’: EU chief says they are close to signing FTA with India; visit scheduled next week - The Times of India

President of the European Commission Ursula von der Leyen talks during the Annual Meeting of the World Economic Forum in Davos (AP photo)

India is close to signing a trade deal with the European Union, as stated by EU chief Ursula von der Leyen during the World Economic Forum in Davos on Tuesday.“There is still work to do. But we are on the cusp of a historic trade agreement. Some call it the mother of all deals. One that would create a market of 2 billion people, accounting for almost a quarter of global GDP,” she said while outlining the EU’s push to expand and diversify its trade partnerships.

EU Puts India At Core Of Historic Trade Reset At Davos, Ursula Leyen Terms It ‘Mother Of All Deals’

She also linked the trade push to forthcoming high-level engagement, saying she will visit India next weekend following the World Economic Forum in Davos. She said the trip is aimed at advancing the proposed trade agreement and underscored that significant work remains to bolster economic ties and deepen cooperation between Europe and India. Von der Leyen is among the chief guests for the 77th Republic Day celebrations. During the India visit, the Eu chief, alongside president of the European Council Antonio Luis Santos da Costa , will also co-chair the 16th India-EU Summit on January 27.Talking about the proposed agreement with India within Europe’s broader global strategy, von der Leyen said the continent remains open to doing business with partners across the world and will continue to pursue active engagement. “Europe will always choose the world, and the world is ready to choose Europe,” she said, emphasising the EU’s determination to expand international trade and cooperation.Last week, Commerce and industry minister Piyush Goyal had also said the free trade agreement between India and EU, where negotiations are in the final phase, will be the “mother of all deals” signed by the country so far. “I have done seven deals so far. All with developed economies. This one will be the mother of all,” the union minister said.He added that, “we are getting a super deal. In areas of EU interest also, we are giving them a super deal. It has to be a win-win. The good part is we do not compete with each other. We have different interests.”Before Goyal, commerce secretary Rajesh Agrawal said the two sides had completed negotiations on 20 of the 24 chapters, with efforts ongoing to conclude the talks by January 26.

Liverpool’s Dominik Szoboszlai confirms contract talks after ‘tough’ week

0
Liverpool's Dominik Szoboszlai confirms contract talks after 'tough' week

Dominik Szoboszlai has revealed talks over a new contract with Liverpool are ongoing but said he is yet to make a decision about his future.

The midfielder has been a standout performer for Arne Slot’s side this term, with six goals and four assists in all competitions. His impressive form has seen him tipped in some quarters to become a future Liverpool captain, though his current deal is set to expire in 2028.

“There is always progress but no decision has been made and I’ll just keep on going every week, every training, giving my best for the team, for the fans,” Szoboszlai said when asked about his contract negotiations. “Let’s see what is going to happen in the future.

“There are always talks. You guys in the media make a lot for the [public] and you keep on going because that’s your job but there has been talks but for sure not any decision has been made.

“Of course I am happy here but you know how football works and that is something everybody has to take into account.”

Despite a number of eye-catching displays this season, it has been a challenging week for Szoboszlai, who missed a penalty in Liverpool’s 1-1 draw with Burnley at the weekend.

The Hungary international was also branded “disrespectful” by Barnsley boss Conor Hourihane after he tried to backheel the ball inside his own penalty area during last week’s FA Cup tie at Anfield.

“For me, personally, it’s a tough one,” he said. “I made a mistake against Barnsley but I have to make it clear it wasn’t disrespectful in my opinion and I would do the same against Arsenal, City and against Chelsea as well.

“I didn’t want to give it back to Giorgi [Mamardashvili], I wanted to keep going but I tried to pretend that was playing it back just to make it clear. [On Saturday], I missed a penalty but I’m going to keep on going, I’m going to take the next one and I’m going to score I’m pretty sure.

“You have to forget it, that’s the best, but of course you have to have learned from it. To be honest if you see me after every session I cannot practise more — and I’m not allowed to practise more because I’m practising as much as I can. I will keep on practising and if I have another chance I will take it.”

Liverpool’s margin for error shrinks with Burnley draw
Robertson on Szoboszlai backheel: Maybe Kop support ‘went to his head’

Liverpool will return to Champions League action on Wednesday night when they take on Marseille at Stade Vélodrome. Slot’s side are currently ninth in the Champions League table and need a positive result in France to boost their hopes of automatically qualifying for the knockout stages.

“It is very important,” Szoboszlai said. “We have to look at the game that it is a big chance to take a big step towards the top eight. If you look at the whole season we have so many games so if you are in the top eight you miss two and that is very important. We have to be ready because we face a really good team.”

US Visa Bond explained: Full list of 38 affected countries, and ports of entry | – The Times of India

0
US Visa Bond explained: Full list of 38 affected countries, and ports of entry | - The Times of India

The United States Department of State has officially announced the expansion of its visa-bond pilot programme, listing a series of countries whose nationals may have to pay a refundable bond when applying for US business or tourist visas. The updated list, issued on Jan 8, 2026, specifies who will be affected, and when the rule would come into force and how it would function.

What are visa bonds

Visa bonds are monetary assurances demanded of some non-immigrant visa applicants to guarantee their adherence to US immigration protocols. According to the terms of this pilot programme, individuals who are otherwise qualified for a B1/B2 visa, usually used for short-term business or tourism, might be asked to pay a bond of $5,000, $10,000 or $15,000.

Trump Visa Crackdown Hits India’s Neighbours, US Pauses Immigration For Pakistan, Bangladesh, Nepal

us visa bond

The policy is based on INA Section 221(g)(3) and a TFR that implements the pilot. The chosen countries have higher B1/B2 overstay rates relative to the rest of the countries as per Department of Homeland Security Entry/Exit Overstay Report.

Countries subjected to visa bonds

Visa Bonds may apply for nationals on passports from the below list: The dates of application in each country are given in brackets:

  1. Algeria (January 21, 2026)
  2. Angola (January 21, 2026)
  3. Antigua and Barbuda (January 21, 2026)
  4. Bangladesh (January 21, 2026)
  5. Benin (January 21, 2026)
  6. Bhutan (January 1, 2026)
  7. Botswana (January 1, 2026)
  8. Burundi (January 21, 2026)
  9. Cabo Verde (January 21, 2026)
  10. Central African Republic (January 1, 2026)
  11. Côte d’Ivoire (January 21, 2026)
  12. Cuba (January 21, 2026)
  13. Djibouti (January 21, 2026)
  14. Dominica (January 21, 2026)
  15. Fiji (January 21, 2026)
  16. Gabon (January 21, 2026)
  17. The Gambia (October 11, 2025)
  18. Guinea (January 1, 2026)
  19. Guinea-Bissau (January 1, 2026)
  20. Kyrgyzstan (January 21, 2026)
  21. Malawi (August 20, 2025)
  22. Mauritania (October 23, 2025)
  23. Namibia (January 1, 2026)
  24. Nepal (January 21, 2026)
  25. Nigeria (January 21, 2026)
  26. Sao Tome and Principe (October 23, 2025)
  27. Senegal (January 21, 2026)
  28. Tajikistan (January 21, 2026)
  29. Tanzania (October 23, 2025)
  30. Togo (January 21, 2026)
  31. Tonga (January 21, 2026)
  32. Turkmenistan (January 1, 2026)
  33. Tuvalu (January 21, 2026)
  34. Uganda (January 21, 2026)
  35. Vanuatu (January 21, 2026)
  36. Venezuela (January 21, 2026)
  37. Zambia (August 20, 2025)
  38. Zimbabwe (January 21, 2026).

This requirement is irrespective of where the visa application is lodged.

How the amount of bond is determined

The amount of the bond, $5,000, $10,000 or $15,000, will be calculated at the time of visa interview. Applicants must also submit the Department of Homeland Security Form I-352 (Immigration Bond) and make a formal undertaking on the bond.Most importantly, the payment of a bond is not a guarantee that you will receive your visa. If an applicant pays without instruction specific to a consular officer, the funds will not be refunded.

Who to pay the bond to and where it must be paid

Form I-352 should not be submitted until the consular officer directs the applicant to do so. Payments are made only via Pay.gov, the federal government’s official E-Payments platform.The State Department has advised applicants not to use third-party websites or agents. Any money paid outside official US government systems is not the responsibility of the US government.

Designated ports of entry

Those who post visa bonds are subject to stringent rules for entering and leaving the country. Bonded visa holders are limited to entering and departing the country through specific ports of entry. Failure to comply may lead to denied entry or an unrecorded departure, which could affect bond refunds.

airport

Currently designated ports include:

Boston Logan International Airport (BOS) – from August 20, 2025John F. Kennedy International Airport (JFK) – from August 20, 2025Washington Dulles International Airport (IAD) – from August 20, 2025Newark Liberty International Airport (EWR) – from January 1, 2026Hartsfield-Jackson Atlanta International Airport (ATL) – from January 1, 2026Chicago O’Hare International Airport (ORD) – from January 1, 2026Los Angeles International Airport (LAX) – from January 1, 2026Toronto Pearson International Airport (YYZ) – from January 1, 2026Montréal-Pierre Elliott Trudeau International Airport (YUL) – from January 1, 2026Additional ports will be added in phases.

When the bond is refunded

The visa bond is refunded when:

  • DHS data indicate the visa holder left before or on the authorised date of stay.
  • The visa holder never travels to the US before visa expiry.
  • The visa holder applies for entry but is denied admission at a US port.

The bond is meant to ensure compliance, not to generate revenue.

What constitutes a bond breach

If DHS suspects a bond violation, the case will be referred to US Citizenship and Immigration Services for investigation. A bond may be forfeited if:The visa holder departs after the authorised stay period.The visa holder overstays and fails to leave.The visa holder applies for an adjustment of status, such as asylum.

What applicants need to know

US officials repeatedly emphasise that applicants should follow official instructions, make payments only after visa approval, and avoid intermediaries. As the pilot expands, affected travellers should include potential bond costs in their financial and travel planning.

FDA clears first at-home brain device for depression

0
FDA clears first at-home brain device for depression

NEWYou can now listen to Fox News articles!

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. 

The approval comes from the U.S. Food and Drug Administration and marks a major shift in how mental health conditions may be treated. The newly approved device is called FL-100, and it comes from Flow Neuroscience. 

It is designed for adults 18 and older with moderate to severe major depressive disorder. Clinicians can prescribe it as a stand-alone treatment or alongside antidepressants and therapy. This decision matters because depression affects more than 20 million adults in the U.S. Roughly one-third do not get enough relief from medication or stop taking it due to side effects.

Sign up for my FREE CyberGuy Report
Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide – free when you join my CYBERGUY.COM newsletter.

SIMPLE DAILY HABIT MAY HELP EASE DEPRESSION MORE THAN MEDICATION, RESEARCHERS SAY

Flow Neuroscience has gotten approval from the U.S. Food and Drug Administration for its FL-100 prescription brain-stimulation device. (Flow Neuroscience)

How the Flow FL-100 works

The FL-100 uses transcranial direct current stimulation, often shortened to tDCS. This technology delivers a gentle electrical current to the prefrontal cortex, a region of the brain tied to mood regulation and stress response. In many people with depression, activity in this area is reduced. By stimulating it, the device aims to restore healthier brain signaling over time. The system looks like a lightweight headset and pairs with a mobile app. Patients use it at home for about 30 minutes per day while clinicians monitor progress remotely.

The clinical results behind the approval

The FDA based its decision on a randomized controlled trial that evaluated home use under remote supervision. Participants who received active stimulation showed meaningful improvement on clinician-rated and self-reported depression scales. After 10 weeks of treatment, patients experienced an average symptom improvement of 58% compared to a control group. Many users reported noticeable changes within the first three weeks. The study was published in the journal Nature Medicine, adding credibility to the findings. Side effects were generally mild and short-term. Reported issues included skin irritation, redness, headaches, and brief stinging sensations at the electrode sites.

FDA sign.

The FDA has approved the first prescription brain-stimulation device for at-home treatment of depression in the U.S., marking a major shift in mental healthcare. (hoto by ISSAM AHMED/AFP via Getty Images)

A growing shift toward tech-based mental health care

Flow’s device has already been used by more than 55,000 people across Europe, the U.K., Switzerland and Hong Kong. In the U.K., it is prescribed within parts of the public health system. Company leaders say the U.S. approval opens the door for broader access to non-drug treatment options. The momentum is not isolated. In 2025, researchers at UCLA Health developed another experimental brain-stimulation approach, signaling rapid growth in this field. Together, these advances suggest that at-home neuromodulation may soon become a standard part of depression care rather than a fringe option.

When will the device be available

Flow expects the FL-100 to be available to U.S. patients in the second quarter of 2026. A prescription will be required, and the companion app will be available on iOS and Android. The company also plans to explore additional uses for its platform, including sleep disorders, addiction, and traumatic brain injury.

10 HEALTH TECH PRODUCTS STEALING THE SPOTLIGHT AT CES 2026

Flow Neuroscience brain-stimulation device

Flow Neuroscience’s FL-100 headset delivers mild electrical stimulation to the brain and can be prescribed for home use under medical supervision. (Flow Neuroscience)

What to know before trying Flow

Flow is FDA approved for adults 18 and older with moderate to severe major depressive disorder, and it requires a prescription from a licensed healthcare provider. Doctors can recommend it on its own or alongside medication or therapy. The headset is non-invasive and designed for home use, but it is not meant for emergency situations or people considered treatment resistant. It also does not replace crisis care or immediate mental health support. Most users wear the headset for about 30 minutes per session. Mild tingling, warmth, skin irritation or headaches can happen, especially early on. These effects are usually short-lived and monitored by a clinician through the companion app.

Flow pairs with a mobile app that guides treatment and supports remote clinical oversight. Your provider sets the treatment plan, and the device follows prescribed settings to ensure safe use. Pricing and insurance coverage may vary once the device becomes available in the U.S. Some patients may access Flow through clinics, research programs, or as it becomes more widely adopted in routine depression care. The bottom line is simple. Flow adds another evidence-based option, not a cure and not a one-size-fits-all solution. For people who have struggled to find relief, having another clinically proven choice can matter a lot.

What this means to you

If you or someone you care about struggles with depression, this approval expands the range of real treatment options. It offers a non-drug path that can be used at home under medical guidance. For patients who have not responded well to medication or who experience unwanted side effects, this could provide another way forward. It also reflects a broader trend toward personalized, tech-enabled mental healthcare. 

Take my quiz: How safe is your online security?

Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com.

ELON MUSK SHARES PLAN TO MASS-PRODUCE BRAIN IMPLANTS FOR PARALYSIS, NEUROLOGICAL DISEASE

FDA logo.

The newly approved device targets adults with moderate to severe depression and can be used alongside medication or therapy. (Photo by Sarah Silbiger/Getty Images)

Kurt’s key takeaways

This FDA approval feels like a real turning point. For years, brain stimulation for depression stayed locked inside clinics. Now it can happen at home with a doctor still guiding the process. That matters for people who have tried medications, dealt with side effects or felt stuck with limited options. This device will not be the right answer for everyone, but it gives patients and doctors one more proven tool to work with. And for many people living with depression, having another option could make all the difference.

If a doctor could prescribe a brain-stimulation headset instead of another pill, would you be open to trying it? Let us know by writing to us at Cyberguy.com.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Sign up for my FREE CyberGuy Report
Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide – free when you join my CYBERGUY.COM newsletter.

Copyright 2026 CyberGuy.com.  All rights reserved.

Access Denied

0
Access Denied


Access Denied

You don’t have permission to access “http://food.ndtv.com/news/viral-video-of-nanis-refrigerator-filled-to-the-brim-gets-the-internet-talking-10790004” on this server.

Reference #18.dd711102.1768931367.1e9c13ce

https://errors.edgesuite.net/18.dd711102.1768931367.1e9c13ce

Gastric sleeve surgery was ‘life-changing’

0
Gastric sleeve surgery was 'life-changing'

Steph Hoy dropped from 25 stone to eight stone after surgery.

Piers Morgan finally reacts to Brooklyn Beckham’s statement about David and Victoria Beckham

0
Piers Morgan finally reacts to Brooklyn Beckham

Brooklyn Beckham said “I do not want to reconcile with my family.”

Outspoken journalist Piers Morgan has reacted to Brooklyn Beckham’s statement, in which he said he does not want to reconcile with his family –David Beckham and Victoria Beckham.

Brooklyn Peltz Beckham, the elder son of the British celebrity couple David and Victoria Beckham, said he did not want to reconcile with his parents after a family rift he described in a lengthy post on social media on Monday.

The 26-year-old said that his parents have been controlling narratives in the press about his family and tried to “ruin” his relationship with his wife Nicola Peltz Beckham.

He released the statement on Instagram, saying “I do not want to reconcile with my family.

“I´m not being controlled, I´m standing up for myself for the first time in my life.”

Brooklyn married Nicola, an American actress and the daughter of billionaire businessman Nelson Peltz and former model Claudia Heffner Peltz, in 2022.

According to AFP, the spokespeople for David and Victoria Beckham did not immediately respond to its request for comment on their son´s statements.

“My parents have been trying endlessly to ruin my relationship since before my wedding, and it hasn´t stopped,” Brooklyn Peltz Beckham said.

“My mum cancelled making Nicola´s dress in the eleventh hour despite how excited she was to wear her design, forcing her to urgently find a new dress.”

Morgan, who is recovering in hospital from a hip replacement after tripping on a small step at a London restaurant, tweeted: “I didn’t think anything could be more excruciatingly embarrassing and eye-poppingly painful than fracturing a femur in a restaurant so badly I needed a new hip… but the Beckham family saga has managed it! What a repellent bunch of fake, narcissistic PR-obsessed twerps.”